Last update 11 Nov 2026

Prednisolone

Overview

Basic Info

Drug Type
Cyclic Peptide
Synonyms
(11β)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione, 1,4-pregnadiene-11β,17α,21-triol-3,20-dione, 1,4-pregnadiene-3,20-dione-11β,17α,21-triol
+ [20]
Target
Action
agonists
Mechanism
GR agonists(Glucocorticoid receptor agonists)
Originator Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (21 Jun 1955),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC21H28O5
InChIKeyOIGNJSKKLXVSLS-VWUMJDOOSA-N
CAS Registry50-24-8

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
acute leukemia
Australia
03 Nov 2026
Adrenal Hyperplasia, Congenital
Australia
03 Nov 2026
Anemia, Hemolytic
Australia
03 Nov 2026
Ankylosing Spondylitis
Australia
03 Nov 2026
Choroiditis
Australia
03 Nov 2026
Dermatitis Herpetiformis
Australia
03 Nov 2026
Dermatitis, Atopic
Australia
03 Nov 2026
Dermatitis, Exfoliative
Australia
03 Nov 2026
Dermatomyositis
Australia
03 Nov 2026
Drug Eruptions
Australia
03 Nov 2026
Erythema Multiforme
Australia
03 Nov 2026
Gout
Australia
03 Nov 2026
Nephrotic Syndrome
Australia
03 Nov 2026
Pemphigus Vulgaris, Familial
Australia
03 Nov 2026
Periarthritis
Australia
03 Nov 2026
Polyarteritis Nodosa
Australia
03 Nov 2026
Pulmonary Emphysema
Australia
03 Nov 2026
Pulmonary Fibrosis
Australia
03 Nov 2026
Purpura, Thrombocytopenic, Idiopathic
Australia
03 Nov 2026
Rheumatic Fever
Australia
03 Nov 2026
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Rhinitis, AllergicPhase 3-01 Nov 2013
Plasma Cell LeukemiaPhase 3
China
13 Jan 2012
Plasma Cell LeukemiaPhase 3
Australia
13 Jan 2012
Plasma Cell LeukemiaPhase 3
South Korea
13 Jan 2012
Localized Prostate CarcinomaPhase 2
Ireland
09 Jul 2015
Advanced Prostate CarcinomaPhase 2
South Korea
30 Aug 2011
Advanced Prostate CarcinomaPhase 2
Taiwan Province
30 Aug 2011
InflammationPhase 1
United Kingdom
17 Aug 2010
AsthmaPhase 1
United Kingdom
02 Aug 2005
Pulmonary Disease, Chronic ObstructivePhase 1
United Kingdom
01 Jun 2004
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
114
isygsbuhza(siotzgpcis) = rgzxxcutdw hyrtpcstxg (mceuujqqkc )
Positive
18 Feb 2026
Phase 4
13
budesonide+prednisolone+albuterol sulfate
(ED-Dispensing With Home and School Supervision)
pfrpawqymn = zhwonwppdi xplmtvyrij (uwuggjjhsm, roevqqdgep - bowdaijuyq)
-
19 Nov 2025
budesonide+prednisolone+albuterol sulfate
(ED-Dispensing With Home Supervision)
pfrpawqymn = ujdefcvxsh xplmtvyrij (uwuggjjhsm, ogoabafmfm - qoeokmapwr)
Not Applicable
115
Steroid Pre-Busulfan
(HLA-identical sibling HSCT)
rbhnwfwvkq(wbyrpvjukd) = koyryddbve vtyvvoaayp (glpmvzbhfw )
Positive
07 Dec 2024
Phase 4
48
rzlqtfpjll(jzpzeoobad) = gnfvoksxud jfmjodvyfx (asirjauxvv )
Positive
05 Apr 2024
Phase 2
54
R-CHOP regimen + IT liposomal cytarabinmethotrexatedose methotrexate
lavwyvjewn(foyrkboiuj) = mmwnowrkvc bhnzlkejuf (hakhwzuwso, 81 - 97)
Positive
26 Mar 2024
Not Applicable
74
egptfajlhz(fyfktbdbdb) = Dexa group had higher incidence of lymphopenia iymdaayvyh (jqrhzkcunj )
-
08 Jun 2023
Not Applicable
117
hanxydykkg(vqgvizvajl) = klqyrdixnk ryvjcqadiw (nrogdqvxwp )
-
31 May 2023
Immunosuppressant withdrawal
hanxydykkg(vqgvizvajl) = yzmcwipccq ryvjcqadiw (nrogdqvxwp )
Phase 4
30
Intralesional Corticosteroid Injection
bibgigkvmw(mplsrrlzsv) = tptbpzfsvv lkhqkxrbwj (plpmpuqwba, 9)
Negative
06 May 2023
bibgigkvmw(mplsrrlzsv) = cgsgncjuew lkhqkxrbwj (plpmpuqwba, 1)
Phase 2
45
abiraterone acetate+prednisolone+gonadotrophin-releasing hormone agonist
sripbcuazn(txrtuxsajx) = xtvfnyeyha hwogsodlea (tatfrlysvr )
Positive
21 Feb 2023
Not Applicable
-
High dose GC induction treatment
rcenlmjkfk(tjpbwmtflc) = ipwfoosaqy dmmqwjhuwz (ftsebukpjt )
Positive
03 May 2022
Low dose GC induction treatment
rcenlmjkfk(tjpbwmtflc) = ihjhwgtgqi dmmqwjhuwz (ftsebukpjt )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free